Back to mobile site

Thermo Fisher Scientific (TMO) PT Lowered to $692 at RBC Capital

December 20, 2024 9:35 AM EST Send to a Friend
RBC Capital analyst Conor McNamara lowered the price target on Thermo Fisher Scientific (NYSE: TMO) to $692.00 (from $711.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login